Nestlé Health Science Refocuses As It Drops Peanut Allergy Treatment

 
• By Tom Gallen

VMS, active nutrition and medical nutrition will be Nestle Health Science's main focus areas going forward with the business looking to offload peanut allergy treatment Palforzia. The Swiss firm announced the move as it reported organic growth of 4% at Health Science for 2022.

• Source: Shutterstock

More from Strategy

More from Business